Real-World Outcomes across Baseline Risk Profiles in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate in Spain: Insights from the ORESTES Study. [PDF]
Pulm TherAlcázar-Navarrete B +15 more
europepmc +1 more source
An updated meta-analysis of head-to-head trials comparing the efficacy, safety, and adherence of mirabegron and vibegron in overactive bladder. [PDF]
Medicine (Baltimore)Bai WZ, Zhou SY, Mou YY, Peng L, Li LL.
europepmc +1 more source
Systematic evaluation of Tox21 compounds that target β-adrenergic receptors and their role in cardiotoxicity. [PDF]
Toxicol Appl PharmacolLuo X +17 more
europepmc +1 more source
Biased Orthosteric Agonism and Allosteric Modulation: Emerging Strategies for Developing New Class of β-Agonists for Obstructive Airway Diseases. [PDF]
Am J Respir Cell Mol BiolShah SD, Deshpande DA.
europepmc +1 more source
Long-acting β<sub>2</sub> agonist (LABA) with a long-acting muscarinic receptor antagonist (LAMA) promotes human airway smooth muscle (HASM) relaxation and circumvents β<sub>2</sub> adrenergic receptor tachyphylaxis. [PDF]
Respir ResJude J +5 more
europepmc +1 more source
SENSIT, a Modular Single-Chain Fluorescent Integrator Platform for GPCR Ligands. [PDF]
ACS Chem BiolPutansu A +9 more
europepmc +1 more source
Emerging opportunities in ROP therapy: from inhibiting pathological vessel growth to promoting physiological vascularization. [PDF]
Front Med (Lausanne)Filippi L +4 more
europepmc +1 more source
Recognising and managing albuterol-induced lactic acidosis. [PDF]
BMJ Case RepBaddam S, Muttineni S.
europepmc +1 more source